Takeda Pharmaceutical
TAK
#500
Rank
NZ$89.23 B
Marketcap
NZ$28.24
Share price
0.09%
Change (1 day)
11.29%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): NZ$5.55 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are NZ$29.86 Billion. , an increase over its 2024 earnings that were of NZ$3.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 NZ$5.87 B49.03%
2024 NZ$3.94 B-2.41%
2023 NZ$4.03 B-28.14%
2022 NZ$5.61 B-40.9%
2021 NZ$9.50 B78.24%
2020 NZ$5.33 B246.1%
2019 NZ$1.54 B-48.79%
2018 NZ$3.00 B-23.64%
2017 NZ$3.94 B21.7%
2016 NZ$3.23 B-253.01%
2015 -NZ$2.12 Billion-159.65%
2014 NZ$3.54 B13%
2013 NZ$3.13 B2.46%
2012 NZ$3.06 B-57.05%
2011 NZ$7.13 B-10.49%
2010 NZ$7.96 B-3.99%
2009 NZ$8.29 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.86 B 681.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.86 B 374.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.69 B 218.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.04 B 173.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.52 B 130.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$23.22 B 295.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.67 B 201.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-NZ$1.4 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.54 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India